Evidence map›Paper›PMID 35265629›Full record

ArticleFrontiers in cell and developmental biology2021

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients.

Taohua Yue, Xiangzheng Liu, Shuai Zuo, Jing Zhu, Jichang Li, Yucun Liu, Shanwen Chen, Pengyuan Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Taohua YueDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Xiangzheng LiuDepartment of Thoracic Surgery, Peking University First Hospital, Peking University, Beijing, China.
Shuai ZuoDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Jing ZhuDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Jichang LiDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Yucun LiuDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Shanwen ChenDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Pengyuan WangDivision of General Surgery, Peking University First Hospital, Peking University, Beijing, China.
Peking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BCL2A1CCL18chemotherapycolon cancerimmunotherapyPD-L1

Identifiers

PMID35265629
PMCPMC8898943
OpenAlexW4212889952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.